Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases

  4. Siemens Healthineers Introduces Biograph Vision Quadra Extended Axial FoV PET/CT Scanner

Press release

Siemens Healthineers Introduces Biograph Vision Quadra Extended Axial FoV PET/CT Scanner

Published on October 23, 2020

Congress of the European Association of Nuclear Medicine

The remote-controlled LUMINOS Lotus Max system offers tremendous versatility in clinical examinations, as it combines radiographic and fluoroscopic imaging with orthopedic studies such as long leg or spinal examinations and basic interventions. Copyright: Siemens Healthineers

Siemens Healthineers introduces the Biograph Vision Quadra, a CE-Marked PET/CT scanner that is designed for clinical use as well as translational research.

Not for publication in the USA

  • Large 106 cm axial PET field of view enables simultaneous whole-body imaging from top of head to thigh
  • Industry’s most sensitive extended field of view scanner¹ designed for clinical and research use

During the virtual 33rd Annual Congress of the European Association of Nuclear Medicine (EANM), Oct. 22-30, Siemens Healthineers introduces the Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research – or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.

In addition to the 3.2 mm silicon photomultiplier (SiPM) detector technology and Time of Flight (ToF) performance that are cornerstones of the established Biograph Vision PET/CT scanner, the Biograph Vision Quadra has an extended 106 cm axial field of view (FoV) – four times the PET axial FoV of the Biograph Vision 600. These technological features deliver significantly increased effective sensitivity¹ and enable the clinician to image the average patient dynamically from the top of the head to the thigh in just one position. With the scanner’s extended axial FoV, the clinician can examine patient anatomy during radiopharmaceutical uptake over time. The combination of SiPM detectors and extended axial FoV permits more anatomical coverage in one bed position than a standard PET/CT scanner, enabling fast scanning at low patient radiation dose.

“The Biograph Vision Quadra is an order of magnitude more powerful than current state-of-the-art clinical scanners available today¹,” said James Williams, Head of the Molecular Imaging business at Siemens Healthineers. “This scanner will open possibilities for the imaging of complex and subtle biological processes that are key to the understanding of both physiology and pathophysiology alike.”

The Biograph Vision Quadra can be sited in the same clinical space as traditional PET/CT scanners, so the institution does not need to construct a large new room to house the scanner.

Download this press release(pdf, 155.74 KB)
1

Based on data at time of publication. Data on file.

Siemens Healthineers 2021

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.